LZO: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented
What it covers
A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A1203) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.
The identification in 21 CFR 888.3353, hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis. FDA gives LZO no definition of its own, so the regulation’s describes it.
FDA flags LZO devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262473 | NEXUS® Hip Stem | Microport Orthopedics, Inc. | Oct 1, 2026 | Special |
| K260173 | M-Vizion Femoral Revision System Extension | Medacta International S.A. | Sep 17, 2026 | Traditional |
| K253948 | Momentum Acetabular Cup System | United Orthopedic Corporation | Sep 2, 2026 | Traditional |
| K261009 | MobileLink Acetabular Cup System 40mm ID Inserts (various) | Waldemar Link GmbH & Co. KG | Jul 6, 2026 | Traditional |
| K260831 | Z1 Hip System | Zimmer, Inc. | Jun 16, 2026 | Traditional |
| K260182 | Avenir® Müller Stem; Avenir Complete Hip System | Zimmer, Inc. | Apr 27, 2026 | Traditional |
| K260037 | implantcast Packaging System Update | Implantcast GmbH | Mar 30, 2026 | Traditional |
| K252401 | implaFit® short stems | Implantcast GmbH | Mar 12, 2026 | Traditional |
| K253171 | Libertas Taper Short (TS) Uncemented Femoral Stem (Libertas TS Stem) | Maxx Orthopedics, Inc. | Jan 15, 2026 | Traditional |
| K250450 | Coated hip implants | Medacta International S.A. | Sep 19, 2025 | Traditional |
Clearances by year
235 LZO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 9 | 102 |
| 2025 | 14 | 119 |
| 2024 | 11 | 111 |
| 2023 | 10 | 122 |
| 2022 | 11 | 279 |
| 2021 | 12 | 170 |
| 2020 | 18 | 112 |
| 2019 | 28 | 109 |
| 2018 | 18 | 163 |
| 2017 | 16 | 257 |
| 2016 | 10 | 177 |
| 2015 | 12 | 115 |
| 2014 | 13 | 85 |
| 2013 | 26 | 100 |
| 2012 | 14 | 98 |
| 2011 | 13 | 87 |
Who submits
56 applicants cleared a LZO device since 2011. 57% of the clearances went to applicants in United States, then Switzerland (14%), Germany (10%) and Taiwan (5%). By type: Traditional 75%, Special 24% and Abbreviated 1%.
| Applicant | Clearances since 2011 |
|---|---|
| Medacta International S.A. | 24 |
| Corin USA | 17 |
| Microport Orthopedics, Inc. | 13 |
| Smith & Nephew, Inc. | 12 |
| Waldemar Link GmbH & Co. KG | 11 |
| Implantcast GmbH | 10 |
| Medacta International | 10 |
| Zimmer GmbH | 10 |
How FDA classifies it
Class II.
From 21 CFR 888.3353.
Standards
21 CFR 888.3353 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LZO clearances declared.
Ask about LZO
Questions about LZO
What is FDA product code LZO?
Product code LZO, “Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3353 (hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 535 clearances under LZO, 235 of them since 2011.
How many 510(k) clearances are there under LZO?
FDA’s 510(k) database listed 535 clearances under LZO as of Oct 29, 2026, 235 of them decided since 2011; the most recent decision was Oct 1, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LZO 510(k)?
For the 25 LZO clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 102 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LZO clearances?
Since 2011: Medacta International S.A. (24), Corin USA (17), Microport Orthopedics, Inc. (13), Smith & Nephew, Inc. (12) and Waldemar Link GmbH & Co. KG (11). 56 applicants have cleared a LZO device in that time.